New Horizon Global Pharma

What New Horizon Global Pharma does

New Horizon Global Pharma (NHG Pharma) is a B2B pharmaceutical manufacturer and exporter operating across three jurisdictions. It is headquartered in Dubai as a Free Zone Company (FZCO) and maintains operational subsidiaries in the United States (New Jersey) and Lithuania (Vilnius), positioning it to serve pharmaceutical and food-industry customers across the Gulf, North American, European, and Asia-source markets. The company manufactures and globally distributes Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, modified-release pellets, food-grade chemicals, food additives, and food ingredients, with an API catalog spanning therapeutic categories including analgesics, antiallergics, antiarrhythmics, antibacterials, antifungals, antihistamines, antihypertensives, anti-inflammatories, antivirals, cardiovascular agents, CNS agents, cough and cold preparations, and respiratory drugs.

NHG Pharma's underlying capability centers on broad multi-category API coverage and formulation-technology breadth, supported by long-standing sourcing relationships with established Indian pharmaceutical manufacturers. The pellet technology portfolio includes sustained-release (SR), immediate-release (IR), enteric-coated (EC), and extended-release (ER) formats used in modified-release oral solid dosage forms, while the intermediates catalog supplies multi-step synthesis inputs requiring process chemistry expertise. Food-grade chemicals, food additives, and food ingredients extend the company's addressable market beyond pharmaceuticals into the food industry vertical.

The company's go-to-market model is enterprise B2B field sales with a request-for-quote (RFQ) workflow, multi-year supply contracts, and long-term partnership agreements. Pricing is negotiated contract-by-contract on the basis of volume, purity specifications, regulatory documentation, and lead time, consistent with bulk-API and intermediates distribution economics. The firm was founded in 2018, is privately held, has 11–50 employees, and is led by CEO Hari Kiran Chereddi.

Name

New Horizon Global Pharma

Legal name

New Horizon Global Pharma FZCO

Website

https://nhgpharma.com/

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

New Horizon Global Pharma is a Dubai-headquartered B2B pharmaceutical manufacturer and exporter, distributing APIs, intermediates, modified-release pellets, and food-grade chemicals to global drug and food ingredient manufacturers from offices in the UAE, US, and Lithuania.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients (APIs) Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)

akta.pro secondary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Active Pharmaceutical Ingredients
• Pharmaceutical Intermediates
• Pharmaceutical Pellets
• Food Grade Chemicals
• Pharmaceutical Manufacturing

Headquarters

HQ city

New Jersey

HQ country

Trinidad & Tobago

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. API and Pharmaceutical Ingredient Sales: Primary revenue from manufacturing and exporting Active Pharmaceutical Ingredients, pharma intermediates, pellets, food grade chemicals, food additives and food ingredients to pharmaceutical manufacturers worldwide.
2. Long-term Partnership Model: Revenue generated through sustained partnerships with major pharmaceutical and food additive manufacturers, suggesting recurring transaction-based business model with established clientele

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

New Horizon Global Pharma is a pharmaceutical manufacturer, seller, and exporter that produces Active Pharmaceutical Ingredients (APIs), advanced pharma intermediates, and specialized pellets (Sustained Release, Immediate Release, Enteric Coated, and Extended Release variants), alongside food grade chemicals, food additives, and food ingredients. The company serves global pharmaceutical and food additive manufacturers through direct B2B export from its Dubai headquarters and regional offices in the USA and Lithuania, with long-standing sourcing relationships with major manufacturers in India.

Product overview

New Horizon Global Pharma (NHG Pharma) is a pharmaceutical manufacturer, seller, and exporter offering a diversified product portfolio comprising three core product lines: Active Pharmaceutical Ingredients (APIs), Advanced Pharma Intermediates, and Specialized Pellets, supplemented by Food Grade Chemicals, Food Additives, and Food Ingredients. The company operates across multiple global locations (Dubai, USA, and Lithuania) with established relationships with major pharmaceutical and food additive manufacturers in India. The API portfolio spans cardiovascular, respiratory, neurological, gastrointestinal, anti-inflammatory, antihistamine, and metabolic therapeutic categories with over 100+ formulations. The Intermediates division provides synthesis-stage compounds for numerous pharmaceutical products. The Pellets division offers specialized delivery formulations including SR (Sustained Release), IR (Immediate Release), EC (Enteric Coated), and ER (Extended Release) variants.

Differentiator

Problem solved

Functional benefit

Products and services

• Active Pharmaceutical Ingredients (APIs) A comprehensive portfolio of Active Pharmaceutical Ingredients covering therapeutic areas including cardiovascular, respiratory, neurological, gastrointestinal, anti-inflammatory, antihistamine, and metabolic disorders. Products include formulations such as Abacavir Sulfate, Amlodipine besylate, Clopidogrel Bisulfate, Domperidone Maleate, Duloxetine Hcl, Empagliflozin, Fexofenadine HCl, Levocetirizine Di Hcl, Losartan Potassium, Nebivolol HCL, Olmesartan Medoxomil, Pantoprazole Sodium Sesquihydrate, Pregablin, Sitagliptin, and many others. Targeted at global pharmaceutical manufacturers for drug formulation.
• Pharma Intermediates Chemical compounds formed at various stages during the synthesis of Active Pharmaceutical Ingredients. Includes advanced intermediates for Domperidone, Loratadine, Desloratadine, Losartan Potassium, Olmesartan, Telmisartan, Loperamide HCl, Donepezil, Pantoprazole Sodium, Fexofenadine HCl, Clopidogrel, Nebivolol, Pregabalin, Quetiapine Hemifumarate, Fentanyl, Dolutegravir, Linagliptin, Aripiprazole, Suvorexant, and numerous other pharmaceutical compounds. Targeted at pharmaceutical manufacturers for API synthesis.
• Pharmaceutical Pellets Specialized pellet formulations including Sustained Release (SR), Immediate Release (IR), Enteric Coated (EC), and Extended Release (ER) variants for various pharmaceutical applications. Product range includes Ambroxol HCL SR, Aprepitant IR, Aspirin EC, Clopidogrel IR, Diclofenac Sodium EC/SR, Domperidone formulations, Esomeprazole combinations, Lansoprazole EC, Omeprazole EC, Pantoprazole combinations, Rabeprazole EC, Tramadol SR, and others. Designed for pharmaceutical manufacturers requiring controlled-release drug delivery formulations.
• Food Grade Chemicals Food grade chemicals manufactured to regulatory standards for food industry applications. Supplied to food additive manufacturers across global markets.
• Food Additives Food additives manufactured and supplied to meet food industry quality and safety requirements. Supplied to food additive manufacturers worldwide.
• Food Ingredients Food ingredients supplied to food manufacturers across global markets to meet food industry production requirements.

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Aurobindo Pharma: One of India's largest API and generic finished-dose manufacturers with a massive API portfolio spanning cardiovascular, anti-infectives, and CNS. Comparable to NHG Pharma because both serve global pharmaceutical manufacturers with APIs and intermediates sourced from India.
• Divis Laboratories: Leading Indian manufacturer of APIs and intermediates with focus on custom synthesis for global innovator pharma. Comparable to NHG Pharma in targeting international pharma manufacturers with API supply and intermediates.
• Piramal Pharma Solutions: Global CDMO and API manufacturer with significant Indian operations. Comparable to NHG Pharma as a developer and supplier of APIs and intermediates to international pharmaceutical customers.
• Cambrex Corporation: Global small-molecule API manufacturer with facilities in the US and Europe. Comparable to NHG Pharma as a B2B supplier of APIs and intermediates to pharmaceutical manufacturers.

Direct peers

• Laurus Labs: Indian-headquartered API and intermediates manufacturer with strong positions in antiretroviral, cardiovascular, and oncology APIs. Directly comparable to NHG Pharma as an India-origin API exporter serving global formulation companies.
• MSN Laboratories: Indian API and finished-dose manufacturer with cardiovascular and CNS API presence. Comparable to NHG Pharma as an India-rooted API supplier serving global pharmaceutical customers.
• Dishman Carbogen Amcis: India-based provider of APIs, intermediates, and contract manufacturing services with focus on niche molecules. Closely comparable to NHG Pharma's pharma intermediates and API offering.
• Hikal Limited: Indian manufacturer of APIs, intermediates, and specialty chemicals serving global pharma, agro, and animal health customers. Comparable to NHG Pharma in intermediates-led B2B supply model.

Emerging players

• Spectrum Chemical: US-based distributor of APIs, excipients, and laboratory chemicals, with food-grade and USP-grade product lines. Comparable to NHG Pharma in the distribution, rather than primary manufacturing, of pharmaceutical and food-grade chemical ingredients.

Regional players

• TCI Chemicals: Japan-headquartered global supplier of specialty chemicals, APIs, and reagents with established distribution in Asia, Europe, and the Americas. Comparable to NHG Pharma as a multi-region B2B ingredient supplier to manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/nhg-pharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New Horizon Global Pharma